Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06818682
What this trial is testing

Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial

Who this might be right for
Prostate Carcinoma
Tata Memorial Centre 206
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295447
What this trial is testing

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Universität Münster 190
Not applicableActive Not RecruitingNCT01653093
What this trial is testing

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
University of Cincinnati 280
Not applicableWithdrawnNCT03308734
What this trial is testing

Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Bath
Early research (Phase 1)Study completedNCT02946008
What this trial is testing

Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00039624
What this trial is testing

Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT02300389
What this trial is testing

Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated

Who this might be right for
Prostate Cancer
The Greater Poland Cancer Centre 288
Very early researchLooking for participantsNCT02526368
What this trial is testing

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Ivan de Kouchkovsky, MD 80
Testing effectiveness (Phase 2)WithdrawnNCT02424513
What this trial is testing

Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
ImaginAb, Inc.
Not applicableNot Yet RecruitingNCT07311915
What this trial is testing

Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

Who this might be right for
Prostate Cancer
Zhongda Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04997018
What this trial is testing

MRI-guided High-dose Radiation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT00951535
What this trial is testing

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Who this might be right for
Prostate Cancer
Cancer Trials Ireland 251
Not applicableLooking for participantsNCT07407608
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0

Who this might be right for
Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Non-Metastatic
University of Milano Bicocca 58
Testing effectiveness (Phase 2)Study completedNCT00828308
What this trial is testing

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Brown University 16
Not applicableLooking for participantsNCT07052578
What this trial is testing

Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

Who this might be right for
Prostate Cancer
AstraZeneca 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT03976843
What this trial is testing

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 175
Not applicableNot Yet RecruitingNCT06298838
What this trial is testing

High-resolution Intra-operative PSMA PET-CT in Prostate Cancer

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 10
Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Not applicableLooking for participantsNCT07343349
What this trial is testing

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Who this might be right for
Prostate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate CarcinomaLocally Advanced Prostate Cancer+1 more
Rigshospitalet, Denmark 1,016
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Next Page